316 related articles for article (PubMed ID: 17321327)
1. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
[TBL] [Abstract][Full Text] [Related]
2. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Lee DH; Park KS; Kong ID; Kim JW; Han BG
BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
[TBL] [Abstract][Full Text] [Related]
3. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Ide T; Furuichi Y
Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV)-induced long-term proliferation of CD4+ lymphocytes leading to T lymphoblastoid cell lines carrying EBV.
Guan M; Romano G; Henderson EE
Anticancer Res; 1999; 19(4B):3007-17. PubMed ID: 10652585
[TBL] [Abstract][Full Text] [Related]
5. Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.
Jeon JP; Kim JW; Park B; Nam HY; Shim SM; Lee MH; Han BG
Acta Virol; 2008; 52(3):151-9. PubMed ID: 18999889
[TBL] [Abstract][Full Text] [Related]
6. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
8. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
[TBL] [Abstract][Full Text] [Related]
9. The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells.
Kimura R; Nishioka T; Ishida T
Genes Immun; 2003 Jul; 4(5):356-61. PubMed ID: 12847551
[TBL] [Abstract][Full Text] [Related]
10. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
11. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
Nagy E; Veress G; Szarka K; Csoma E; Beck Z
Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
[TBL] [Abstract][Full Text] [Related]
12. Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.
Unger K; Wienberg J; Riches A; Hieber L; Walch A; Brown A; O'Brien PC; Briscoe C; Gray L; Rodriguez E; Jackl G; Knijnenburg J; Tallini G; Ferguson-Smith M; Zitzelsberger H
Endocr Relat Cancer; 2010 Mar; 17(1):87-98. PubMed ID: 19858224
[TBL] [Abstract][Full Text] [Related]
13. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
Yamashita Y; Tsurumi T; Mori N; Kiyono T
Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells.
Lacoste S; Wiechec E; Dos Santos Silva AG; Guffei A; Williams G; Lowbeer M; Benedek K; Henriksson M; Klein G; Mai S
Oncogene; 2010 Jan; 29(4):503-15. PubMed ID: 19881539
[TBL] [Abstract][Full Text] [Related]
15. The genetic differences between gallbladder and bile duct cancer cell lines.
Saito S; Ghosh M; Morita K; Hirano T; Miwa M; Todoroki T
Oncol Rep; 2006 Nov; 16(5):949-56. PubMed ID: 17016576
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic characterization of human papillomavirus16-transformed foreskin keratinocyte cell line 16-MT.
McGhee EM; Cotter PD; Weier JF; Berline JW; Turner MA; Gormley M; Palefsky JM
Cancer Genet Cytogenet; 2006 Jul; 168(1):36-43. PubMed ID: 16772119
[TBL] [Abstract][Full Text] [Related]
17. Effects of degenerate oligonucleotide-primed polymerase chain reaction amplification and labeling methods on the sensitivity and specificity of metaphase- and array-based comparative genomic hybridization.
Tsubosa Y; Sugihara H; Mukaisho K; Kamitani S; Peng DF; Ling ZQ; Tani T; Hattori T
Cancer Genet Cytogenet; 2005 Apr; 158(2):156-66. PubMed ID: 15796963
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
Sugimoto T; Arai M; Shimada H; Hata A; Seki N
Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line.
Gil Y; Levy-Nabot S; Steinitz M; Laskov R
Mol Immunol; 2007 Jan; 44(4):494-505. PubMed ID: 16574227
[TBL] [Abstract][Full Text] [Related]
20. Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line.
Lee CH; Fang CY; Sheu JJ; Chang Y; Takada K; Chen JY
Cancer Genet Cytogenet; 2008 Aug; 185(1):1-10. PubMed ID: 18656687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
